Association analysis of MALAT1 polymorphisms and risk of psoriasis among Iranian patients

Int J Immunogenet. 2022 Apr;49(2):83-87. doi: 10.1111/iji.12562. Epub 2021 Nov 30.

Abstract

MALAT1 is a long non-coding transcript that affects immune reactions, thus being involved in the pathoaetiology of immune-related conditions. We investigated the associations between two genetic variants in MALAT1 and susceptibility to psoriasis in the Iranian population. The G allele of rs619586 has been shown to be less common among cases versus controls (odds ratios (OR; 95% confidence intervals (CI)) = 0.57 (0.36-0.9)), adjusted p = .02). This single nucleotide polymorphism has been associated with the risk of psoriasis in a dominant model (AG + GG vs. AA: OR (95% CI) = 0.56 (0.35-0.92), adjusted p = .04) as well as log-additive model (OR (95% CI) = 0.59 (0.38-0.92), adjusted p = .04). The rs3200401 was not associated with psoriasis in any of the supposed inheritance models. This study potentiates rs619586 as a risk locus for psoriasis in the Iranian population.

Keywords: MALAT1; lncRNA; psoriasis; rs3200401; rs619586.

MeSH terms

  • Case-Control Studies
  • Genetic Predisposition to Disease
  • Humans
  • Iran / epidemiology
  • Polymorphism, Single Nucleotide
  • Psoriasis* / epidemiology
  • Psoriasis* / genetics
  • RNA, Long Noncoding* / genetics

Substances

  • MALAT1 long non-coding RNA, human
  • RNA, Long Noncoding